Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: A 82Rb PET/CT study

Journal of Nuclear Medicine

Volumn 48, Issue 3, 2007, Pages 349-358

  Dorbala, Sharmila ^a   Vangala, Divya ^a   Sampson, Uchechukwu ^a   Limaye, Atul ^a   Kwong, Raymond ^a   Di Carli, Marcelo F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Rest and stress ejection fraction; Severe coronary artery disease; Vasodilator stress

Indexed keywords

RUBIDIUM 82; DIAGNOSTIC AGENT; RUBIDIUM; VASODILATOR AGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCINTIGRAPHY; AGED; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY;

ADULT; AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RUBIDIUM RADIOISOTOPES; STROKE VOLUME; TOMOGRAPHY, X-RAY COMPUTED; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 34247208691     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Emond M, Mock MB, Davis KB, et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90:2645-2657.
2. Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: executive summary - a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol. 2003;42:1318-1333.
3. Christian TF, Miller TD, Bailey KR, Gibbons RJ. Noninvasive identification of severe coronary artery disease using exercise tomographic thallium-201 imaging. Am J Cardiol. 1992;70:14-20.
4. Rehn T, Griffith LS, Achuff SC, et al. Exercise thallium-201 myocardial imaging in left main coronary artery disease: sensitive but not specific. Am J Cardiol. 1981;48:217-223.
5. Lima RS, Watson DD, Goode AR, et al. Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease. J Am Coll Cardiol. 2003;42:64-70.
6. Dash H, Massie BM, Botvinick EH, Brundage BH. The noninvasive identification of left main and three-vessel coronary artery disease by myocardial stress perfusion scintigraphy and treadmill exercise electrocardiography. Circulation. 1979;60:276-284.
7. Nygaard TW, Gibson RS, Ryan JM, Gascho JA, Watson DD, Beller GA. Prevalence of high-risk thallium-201 scintigraphic findings in left main coronary artery stenosis: comparison with patients with multiple- and single-vessel coronary artery disease. Am J Cardiol. 1984;53:462-469.
8. Gibbons RJ, Fyke FE 3rd, Clements IP, Lapeyre AC 3rd, Zinsmeister AR, Brown ML. Noninvasive identification of severe coronary artery disease using exercise radionuclide angiography. J Am Coll Cardiol. 1988;11:28-34.
9. Beanlands RS, Muzik O, Melon P, et al. Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography: determination of extent of altered vascular reactivity. J Am Coll Cardiol. 1995;26:1465-1475.
10. Gregg DE. Effect of coronary perfusion pressure or coronary flow on oxygen usage of the myocardium. Circ Res. 1963;13:497-500.
11. Abel RM, Reis RL. Effects of coronary blood flow and perfusion pressure on left ventricular contractility in dogs. Circ Res. 1970;27:961-971.
12. Bin JP, Le E, Pelberg RA, Coggins MP, Wei K, Kaul S. Mechanism of inducible regional dysfunction during dipyridamole stress. Circulation. 2002;106:112-117.
13. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539-542.
14. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med. 1979;300:1350-1358.
15. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article - a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol. 2002;40:1531-1540.
16. 99mTc-MIBI gated SPECT. J Nucl Med. 2000;41:27-35.
17. Hung GU, Lee KW, Chen CP, Yang KT, Lin WY. Worsening of left ventricular ejection fraction induced by dipyridamole on Tl-201 gated myocardial perfusion imaging predicts significant coronary artery disease. J Nucl Cardiol. 2006;13:225-232.
18. Gibbons RJ, Lee KL, Cobb F, Jones RH. Ejection fraction response to exercise in patients with chest pain and normal coronary arteriograms. Circulation. 1981;64:952-957.
19. Shryock JC, Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol. 1997;79:2-10.
20. Nussbacher A, Arie S, Kalil R, et al. Mechanism of adenosine-induced elevation of pulmonary capillary wedge pressure in humans. Circulation. 1995;92:371-379.
21. Komukai K, Hashimoto K, Shibata T, et al. Effect of continuous ATP injection on human hemodynamics. Circ J. 2002;66:926-929.
22. Cates CU, Kronenberg MW, Collins HW, Sandler MP. Dipyridamole radionuclide ventriculography: a test with high specificity for severe coronary artery disease. J Am Coll Cardiol. 1989;13:841-851.
23. Iwamoto T, Bai XJ, Downey HF. Coronary perfusion related changes in myocardial contractile force and systolic ventricular stiffness. Cardiovasc Res. 1994;28:1331-1336.
24. Ogilby JD, Iskandrian AS, Untereker WJ, Heo J, Nguyen TN, Mercuro J. Effect of intravenous adenosine infusion on myocardial perfusion and function: hemodynamic/angiographic and scintigraphic study. Circulation. 1992;86:887-895.
25. Akinboboye OO, Idris O, Chou RL, Sciacca RR, Cannon PJ, Bergmann SR. Absolute quantitation of coronary steal induced by intravenous dipyridamole. J Am Coll Cardiol. 2001;37:109-116.
26. Meerdink DJ, Okada RD, Leppo JA. The effect of dipyridamole on transmural blood flow gradients. Chest. 1989;96:400-405.
27. Leschke M, Schoebel FC, Vogt M, et al. Reduced peripheral and coronary vasomotion in systemic hypertension. Eur Heart J. 1992;13(suppl D):96-9.
28. Sax FL, Cannon RO 3rd, Hanson C, Epstein SE. Impaired forearm vasodilator reserve in patients with microvascular angina: evidence of a generalized disorder of vascular function? N Engl J Med. 1987;317:1366-1370.
29. Hubbard BL, Gibbons RJ, Lapeyre AC 3rd, Zinsmeister AR, Clements IP. Identification of severe coronary artery disease using simple clinical parameters. Arch Intern Med. 1992;152:309-312.
30. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: summary article - a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation. 2003;107:149-158.